N.B. use of COVID-19 treatment still low, as hospitals struggle with respiratory illnesses – CBC

Only a third of province’s Paxlovid pills prescribed so far, pharmacist questions public awareness

Dec 19, 2022

As New Brunswick hospitals struggle with a surge of respiratory illnesses, only about a third of the province’s supply of a COVID-19 treatment has been prescribed, while only a fraction of a COVID-19 preventive treatment has been administered.

Paxlovid has been shown to significantly reduce hospitalizations and deaths among people at high risk of progressing to serious illness from COVID-19, such as seniors and people with compromised immune systems.

But only 5,056 of the 15,200 treatment courses New Brunswick has received from the federal government have been dispensed as of Dec. 6, according to the Department of Health.

This, despite the fact that the province expanded eligibility and access to the combination of pills that can be taken at home to treat COVID-19, three months ago.

Read more: https://www.cbc.ca/news/canada/new-brunswick/paxlovid-new-brunswick-covid-19-treatment-drug-pharmacists-evusheld-1.6690918

NationTalk Partners & Sponsors Learn More